BWX Technologies Earnings Calls
| Release date | May 04, 2026 |
| EPS estimate | $0.92 |
| EPS actual | $1.12 |
| EPS Surprise | 21.74% |
| Revenue estimate | 837.466M |
| Revenue actual | 860.2M |
| Revenue Surprise | 2.71% |
| Release date | Feb 23, 2026 |
| EPS estimate | $0.89 |
| EPS actual | $1.08 |
| EPS Surprise | 21.21% |
| Revenue estimate | 837.501M |
| Revenue actual | 885.8M |
| Revenue Surprise | 5.77% |
| Release date | Nov 03, 2025 |
| EPS estimate | $0.85 |
| EPS actual | $1.00 |
| EPS Surprise | 17.23% |
| Revenue estimate | 793.368M |
| Revenue actual | 866.286M |
| Revenue Surprise | 9.19% |
| Release date | Aug 04, 2025 |
| EPS estimate | $0.790 |
| EPS actual | $1.02 |
| EPS Surprise | 29.11% |
| Revenue estimate | 794.014M |
| Revenue actual | 764.039M |
| Revenue Surprise | -3.78% |
Last 4 Quarters for BWX Technologies
Below you can see how BWXT performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Aug 04, 2025 |
| Price on release | $154.51 |
| EPS estimate | $0.790 |
| EPS actual | $1.02 |
| EPS surprise | 29.11% |
| Date | Price |
|---|---|
| Jul 29, 2025 | $150.28 |
| Jul 30, 2025 | $152.38 |
| Jul 31, 2025 | $151.93 |
| Aug 01, 2025 | $149.50 |
| Aug 04, 2025 | $154.51 |
| Aug 05, 2025 | $182.00 |
| Aug 06, 2025 | $179.74 |
| Aug 07, 2025 | $179.53 |
| Aug 08, 2025 | $179.19 |
| 4 days before | 2.81% |
| 4 days after | 15.97% |
| On release day | 17.79% |
| Change in period | 19.24% |
| Release date | Nov 03, 2025 |
| Price on release | $215.86 |
| EPS estimate | $0.85 |
| EPS actual | $1.00 |
| EPS surprise | 17.23% |
| Date | Price |
|---|---|
| Oct 28, 2025 | $207.62 |
| Oct 29, 2025 | $213.69 |
| Oct 30, 2025 | $213.80 |
| Oct 31, 2025 | $213.61 |
| Nov 03, 2025 | $215.86 |
| Nov 04, 2025 | $200.39 |
| Nov 05, 2025 | $198.12 |
| Nov 06, 2025 | $193.93 |
| Nov 07, 2025 | $193.55 |
| 4 days before | 3.97% |
| 4 days after | -10.34% |
| On release day | -7.17% |
| Change in period | -6.78% |
| Release date | Feb 23, 2026 |
| Price on release | $198.38 |
| EPS estimate | $0.89 |
| EPS actual | $1.08 |
| EPS surprise | 21.21% |
| Date | Price |
|---|---|
| Feb 17, 2026 | $201.09 |
| Feb 18, 2026 | $202.25 |
| Feb 19, 2026 | $209.07 |
| Feb 20, 2026 | $206.44 |
| Feb 23, 2026 | $198.38 |
| Feb 24, 2026 | $204.23 |
| Feb 25, 2026 | $208.27 |
| Feb 26, 2026 | $207.24 |
| Feb 27, 2026 | $205.98 |
| 4 days before | -1.35% |
| 4 days after | 3.83% |
| On release day | 2.95% |
| Change in period | 2.43% |
| Release date | May 04, 2026 |
| Price on release | $216.68 |
| EPS estimate | $0.92 |
| EPS actual | $1.12 |
| EPS surprise | 21.74% |
| Date | Price |
|---|---|
| Apr 28, 2026 | $216.23 |
| Apr 29, 2026 | $208.08 |
| Apr 30, 2026 | $216.39 |
| May 01, 2026 | $216.31 |
| May 04, 2026 | $216.68 |
| May 05, 2026 | $206.15 |
| May 06, 2026 | $215.20 |
| May 07, 2026 | $209.89 |
| May 08, 2026 | $205.33 |
| 4 days before | 0.210% |
| 4 days after | -5.24% |
| On release day | -4.86% |
| Change in period | -5.04% |
BWX Technologies Earnings Call Transcript Summary of Q1 2026
BWX Technologies reported a strong start to 2026 with Q1 revenue of $860 million (up 26% YoY, 11% organic), adjusted EBITDA of $148 million (up 14%), and adjusted EPS of $1.12 (up 22%). Backlog grew to $8.7 billion, up 77% YoY, driven by robust government bookings (including $1.4 billion from naval pricing agreement work) and accelerating commercial demand for nuclear components and services. Management highlighted disciplined growth investments: the acquisition of Precision Components Group (PCG) as the first step to establish U.S. commercial nuclear manufacturing capacity, plans for a potential greenfield plant at Mount Vernon, IN, and continued investments in advanced nuclear (TRISO fuel, microreactors) and defense-related enrichment/HPDU programs. Segment performance: Government Operations revenue +4% with backlog near $7 billion and margins expected to exceed 19% for the year; Commercial Operations revenue +121% (39% organic) with adjusted EBITDA margin improving to 12.9% and Kinectrics outperforming expectations. Financial guidance (excludes PCG contribution): revenue of at least $3.75 billion (high‑teens growth), adjusted EBITDA raised to $650M–$665M, EPS $4.60–$4.75, and free cash flow $315M–$330M. Management expects modestly higher full‑year tax rate (<21.5%), CapEx around 6% of sales but potentially rising toward ~7% if greenfield investments proceed, and roughly 55% of EBITDA back‑half weighted. Key investor takeaways: sizable and growing backlog with strong visibility; strategic push to localize U.S. commercial manufacturing to capture accelerating SMR/large‑reactor demand; continued balanced exposure to defense and commercial nuclear markets; and upgraded near‑term financial guidance with disciplined capital deployment.
Sign In
Buy BWXT